The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study

Abstract Purpose This study aims to clarify the relationship between rs2282055, a single-nucleotide polymorphism (SNP) in programmed death-ligand 1 (PD-L1), and TPS. Polcaro et al. (2024) showed that rs822336, a SNP in PD-L1, predicts the effect of immune checkpoint inhibitors (ICIs). However, the s...

Full description

Saved in:
Bibliographic Details
Main Authors: Keiichiro Suminaga, Takashi Nomizo, Hironori Yoshida, Hiroaki Ozasa
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1007/s00432-024-06081-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items